Review Volume 13, Issue 17 pp 21791—21806
Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer’s disease: an adrenergic approach
Figure 2. α1AR-mediated downstream signaling pathway involved in Aβ-induced cerebrovascular abnormalities.